- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NPPA Revises Coronary Stent Prices, DES at Rs 39,186 and BMS at Rs 10,762 from April 2026

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has notified revised ceiling prices for coronary stents, factoring in the Wholesale Price Index (WPI) increase of 0.64956% for the year 2025 over 2024.
The revised ceiling prices of coronary stents have been fixed at ₹10,762.15 per unit for Bare Metal Stents (BMS), while Drug Eluting Stents (DES), including metallic DES and Bioresorbable Vascular Scaffolds (BVS)/biodegradable stents, have been priced at ₹39,186.03 per unit.These prices are applicable per stent and are exclusive of GST.
The revision has been issued through Order S.O. 1587(E), in continuation of earlier notifications released between 2018 and 2025 regarding price fixation of coronary stents listed under Sl. No. 28 in Schedule-I of the Drugs (Prices Control) Order, 2013. The revised ceiling prices will come into effect from April 1, 2026, exclusive of Goods and Services Tax (GST), as applicable.
The notice stated,
"In continuation of the notifications issued by the National Pharmaceutical Pricing Authority, Department of Pharmaceuticals, Ministry of Chemical and Fertilizers vide S.O. 639(E) dated 12.02.2018, 1464(E) dated 02.04.2018, 1488(E) dated 29.03.2019, 1217(E) dated 25.03.2020, 1334(E) dated 25.03.2021, 1502(E) dated 30.03.2022, 5249(E) dated 11.11.2022, 1572(E) dated 31.03.2023, 4663(E) dated 25.10.2023, 1551(E) dated 26.03.2024, 1605(E) dated 03.04.2024 and 1473(E) dated 27.03.2025 regarding the fixation of ceiling price of the Coronary Stents as specified in column no. (2) mentioned in the table below; after considering the Wholesale Price Index (WPI) @ 0.64956% for the year 2025 over 2024, it has been decided to revise the ceiling prices of Coronary Stents as mentioned in column no. (4) in the table below, exclusive of Goods and Services Tax as applicable, and unit specified in column (3) with effect from 01.04.2026, as under:
Sl. No. | Coronary Stents (Sl. No. 28 in Schedule-I of the DPCO, 2013) | Unit (in Number) | Ceiling Price (w.e.f. 01.04.2026 with WPI @ 0.64956%) (in Rs) |
(1) | (2) | (3) | (4) |
1 | Bare Metal Stents | 1 | 10,762.15 |
2 | Drug Eluting Stents (DES) including metallic DES and Bioresorbable Vascular Scaffold (BVS)/Biodegradable Stents | 1 | 39,186.03 |
Further, the notification added,
(a) All the existing manufacturers/importers of Coronary Stents having MRP lower than the ceiling price specified in column (4) in the above table (plus Goods and Services Taxes as applicable, if any), may revise the existing MRP of Coronary Stent, on the basis of WPI @ 0.64956% for the year 2025 over 2024 in accordance with Paragraph 16(2) of DPCO, 2013, read with Para 13(2) of DPCO, 2013.
(b) The manufacturers/ importers of Coronary Stents may add Goods and Services Taxes only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (4) of the aforesaid table.
(c) As per Para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer/importers, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same. (d) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
To view the official notice, click the link below:
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.

